Empire Genomics Overview

  • Founded
  • 2006
Founded
  • Status
  • Private
  • Employees
  • 24
Employees
  • Latest Deal Type
  • Debt - PPP
  • Investors
  • 6

Empire Genomics General Information

Description

Developer of molecular and cytogenetic diagnostic platform designed to improve individual patient care. The company's platform assists in advancing biomarker research, accelerating diagnoses and improving personalized treatment options for patients battling cancer and other complex diseases, enabling healthcare providers to diagnose and guide precise therapeutic treatments for their patients.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
  • 1000 Youngs Road
  • Suite 207
  • Williamsville, NY 14221
  • United States
+1 (716) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Empire Genomics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Debt - PPP 30-Apr-2020 00.000 Completed Profitable
5. Later Stage VC 20-May-2016 00.000 00.000 Completed Generating Revenue
4. Debt - General 29-Apr-2016 00.00 Completed Generating Revenue
3. Debt - General 05-Mar-2015 00.00 Completed Startup
2. Seed Round 14-Nov-2014 $1.4M $2.4M Completed Startup
1. Debt - General 13-Jun-2014 $1M $1M Completed Startup
To view Empire Genomics’s complete valuation and funding history, request access »

Empire Genomics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of molecular and cytogenetic diagnostic platform designed to improve individual patient care. The company's pl
Biotechnology
Williamsville, NY
24 As of 2020
00.000
000000000 - 00.000

000000 0

nsectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut eni
0000 000000000
Cambridge, MA
00 As of 0000
00000
00000 00000

00000 00

co laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in volupt
0000000000000
Irving, TX
0000 As of 0000
00.00
0.000 0000-00-00
0000000 0000 00.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Empire Genomics Competitors (27)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Nimbus Therapeutics Venture Capital-Backed Cambridge, MA 00 00000 00000 00000
00000 0000 0000000 Private Equity-Backed Irving, TX 0000 00.00 0000000 0000 00.00
0000000000 Formerly VC-backed Menlo Park, CA 000 00000 00000000 00000
00000000 Formerly VC-backed San Diego, CA 0000 00000 000000&0
0000000000 0000000 Formerly VC-backed Cambridge, MA 0000 00000 00000000000
You’re viewing 5 of 27 competitors. Get the full list »

Empire Genomics Executive Team (9)

Name Title Board Seat Contact Info
Andy Watson Chief Executive Officer
John Rushton Ph.D Chief Operating Officer
Norma Nowak Ph.D Co-Founder, Chief Scientific Officer & Board Member
Anthony Scarpello Chief Commercial Officer
Reza Mazaheri Ph.D Vice President of International Business Development
You’re viewing 5 of 9 executive team members. Get the full list »

Empire Genomics Board Members (3)

Name Representing Role Since
Daniel Penberthy Rand Capital Board Member 000 0000
Norma Nowak Ph.D Empire Genomics Co-Founder, Chief Scientific Officer & Board Member 000 0000
Riyaz Hassanali MD Self Board Member 000 0000
To view Empire Genomics’s complete board members history, request access »

Empire Genomics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Empire Genomics Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Current Yield with Participation Fund PE/Buyout Minority 000 0000 000000 0
BDC Capital Venture Capital Minority 000 0000 000000 0
BroadOak Capital Partners Growth/Expansion Minority 000 0000 000000 0
Rand Capital Business Development Company Minority 000 0000 000000 0
SCP Partners PE/Buyout Minority 000 0000 000000 0
You’re viewing 5 of 6 investors. Get the full list »

Empire Genomics Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00 0000 0000000000 05-Jan-2014 000000000000000000 Biotechnology 0000000 0000000
To view Empire Genomics’s complete acquisitions history, request access »